LANDONI, CLAUDIO
 Distribuzione geografica
Continente #
NA - Nord America 12.035
AS - Asia 5.619
EU - Europa 4.978
SA - Sud America 718
AF - Africa 115
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 5
Totale 23.481
Nazione #
US - Stati Uniti d'America 11.323
SG - Singapore 2.146
CN - Cina 1.400
IT - Italia 1.291
HK - Hong Kong 707
SE - Svezia 707
RU - Federazione Russa 660
CA - Canada 636
BR - Brasile 561
DE - Germania 530
VN - Vietnam 528
IE - Irlanda 472
UA - Ucraina 444
GB - Regno Unito 272
FR - Francia 216
BD - Bangladesh 156
IN - India 128
FI - Finlandia 119
KR - Corea 116
TR - Turchia 65
AR - Argentina 57
IQ - Iraq 56
MX - Messico 49
NL - Olanda 49
PK - Pakistan 44
ID - Indonesia 42
AT - Austria 33
PL - Polonia 33
ZA - Sudafrica 33
JP - Giappone 32
DK - Danimarca 31
TH - Thailandia 30
ES - Italia 28
SA - Arabia Saudita 27
PH - Filippine 26
EC - Ecuador 24
VE - Venezuela 23
BE - Belgio 20
CO - Colombia 19
MA - Marocco 18
CL - Cile 13
UZ - Uzbekistan 13
CH - Svizzera 12
CZ - Repubblica Ceca 12
KE - Kenya 12
LT - Lituania 12
TN - Tunisia 12
MY - Malesia 11
AE - Emirati Arabi Uniti 10
NP - Nepal 10
EG - Egitto 8
JM - Giamaica 8
IL - Israele 7
IR - Iran 7
JO - Giordania 7
KZ - Kazakistan 7
ET - Etiopia 6
OM - Oman 6
PE - Perù 6
PY - Paraguay 6
UY - Uruguay 6
GE - Georgia 5
NG - Nigeria 5
PS - Palestinian Territory 5
PT - Portogallo 5
AL - Albania 4
AZ - Azerbaigian 4
EU - Europa 4
LB - Libano 4
MK - Macedonia 4
SN - Senegal 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
HN - Honduras 3
HU - Ungheria 3
KG - Kirghizistan 3
KW - Kuwait 3
NI - Nicaragua 3
RO - Romania 3
RS - Serbia 3
TW - Taiwan 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
AU - Australia 2
CR - Costa Rica 2
DZ - Algeria 2
GA - Gabon 2
GR - Grecia 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PR - Porto Rico 2
QA - Qatar 2
SC - Seychelles 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
Totale 23.458
Città #
Ann Arbor 1.758
Singapore 1.191
Ashburn 1.067
Woodbridge 828
Houston 798
Fairfield 705
Hong Kong 704
Chandler 588
Jacksonville 483
San Jose 476
Toronto 472
Dublin 450
Wilmington 391
Milan 358
Frankfurt am Main 340
Dearborn 320
Seattle 277
Santa Clara 246
New York 245
Cambridge 215
Beijing 197
Princeton 188
Hefei 184
Ho Chi Minh City 157
The Dalles 157
Chicago 147
Los Angeles 133
Nanjing 127
Dallas 117
Hanoi 113
Lissone 110
Seoul 110
Shanghai 96
Lawrence 89
Lauterbourg 87
Boardman 86
Altamura 80
Lachine 78
Council Bluffs 73
Rome 65
Buffalo 62
Moscow 61
Guangzhou 53
São Paulo 52
Changsha 38
San Diego 37
Shenyang 36
London 34
Dong Ket 33
Nanchang 33
Falls Church 32
Andover 31
Monza 30
Helsinki 29
Brooklyn 27
Fremont 27
Jinan 27
Vienna 27
Bangkok 26
Orem 26
Tokyo 26
Ottawa 24
Columbus 23
Haiphong 23
Mountain View 23
Da Nang 22
Montreal 22
Philadelphia 22
Stockholm 22
Huizen 20
Munich 20
Rio de Janeiro 20
Tianjin 20
Baghdad 19
Paris 19
Warsaw 19
Zhengzhou 19
Brussels 18
Hebei 18
Jakarta 18
Jiaxing 18
Phoenix 16
Porto Alegre 16
Amsterdam 15
Boston 15
Chennai 15
Lahore 15
Dhaka 14
Spoltore 14
Johannesburg 13
Norwalk 13
Tashkent 13
Atlanta 12
Genoa 12
Nuremberg 12
Redondo Beach 12
Jeddah 11
Kunming 11
Mexico City 11
Nairobi 11
Totale 15.713
Nome #
Treatment response assessment in [18F]FDG-PET/CT oncology scans: Impact of count statistics variation and reconstruction protocol 537
Radiomics of the primary tumour as a tool to improve 18F-FDG-PET sensitivity in detecting nodal metastases in endometrial cancer 479
18F-FDG PET/CT in a Case of Metastatic Breast Cancer to the Vulva 461
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients 451
18F-FDG-PET/CT guiding to diagnosis of neurosarcoidosis 436
Cardiotoxicity in breast cancer patients: the role of gated myocardial perfusion SPECT 422
Added diagnostic value of respiratory-gated 4D 18F–FDG PET/CT in the detection of liver lesions: a multicenter study 410
Indicators of guideline-concordant care in lung cancer defined with a modified Delphi method and piloted in a cohort of over 5,800 cases 396
FDG/PET and spiral CT image fusion for medistinal lymph node assessment of non-small cell lung cancer patients 394
18F-FDG PET/CT in preoperative staging of vulvar cancer patients: Is it really effective? 374
Sentinel-node mapping in endometrial cancer patients: comparing SPECT/CT, gamma-probe and dye 365
Impact of Indocyanine Green for Sentinel Lymph Node Mapping in Early Stage Endometrial and Cervical Cancer: Comparison with Conventional Radiotracer 99mTc and/or Blue Dye 364
Baseline 18FDG-PET Metabolic Tumour Volume (MTV) as a Potential Predictive Factor of Response to Metronomic Chemotherapy (mCHT) in HR+/HER2- Metastatic Breast Cancer (MBC) Patients (pts). Preliminary Results of the Metro-pet Study 356
Changes in glucose metabolism during and after radiotherapy in non-small cell lung cancer 333
The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT 322
Multi-modal medical image integration to optimize radiotherapy planning in lung cancer treatment 317
C-11 choline versus F-18 fluorodeoxyglucose for imaging meningiomas: An initial experience 314
The heterogeneity of lung perfusion patterns in SPECT/CT during COVID-19: not only embolism 310
Fluoro-deoxi-glucose uptake and angiogenesis are independent biological features in lung metastases 298
Patients with known or suspected lung cancer: evaluation of clinical management changes due to f-fluorodeoxyglucose positron emission tomography (f-fdg pet) study 296
Evaluation of time of flight (TOF) and point spread function (PSF) reconstructions in the quantification of myocardial blood flow with 13N ammonia and PET: Comparison among reconstructions (reprojection, OSEM), software (PMOD and CARIMAS) and operators 283
Pre-transplant 18FDG-PET predicts outcome in lymphoma patients treated with high-dose sequential chemotherapy followed by autologous stem cell transplantation 273
Role of PET/CT in the clinical management of locally advanced pancreatic cancer 262
Assessment of myocardial perfusion and viability with technetium-99m methoxyisobutylisonitrile and thallium-201 rest redistribution in chronic coronary artery disease 261
The potential role of osteoporosis in unspecific [18F]PSMA-1007 bone uptake 260
Myocardial insulin resistance associated with chronic hypertriglyceridemia and increased FFA levels in Type 2 diabetic patients 260
Clinical Application of a High Sensitivity BGO PET/CT Scanner: Effects of Acquisition Protocols and Reconstruction Parameters on Lesions Quantification 260
Contained rupture of common iliac artery aneurysm in a contrast-enhanced PET/CT study 254
Whole-body scintigraphy with 99Tcm-mibi, 18f-fdg and 131I in patients with metastatic thyroid carcinoma 252
Positron emission tomograhy for the assessment of myocardial viability: A sinopsys of methods and indications 251
Post-therapy surveillance of patients with uterine cancers: value of integrated FDG PET/CT in the detection of recurrence 247
An automatic classification technique for attenuation correction in positron emission tomography 246
Myocardial glucose uptake evaluated by positron emission tomography and fluorodeoxyglucose during hyperglycemic clamp in IDDM patients: Role of free fatty acid and insulin levels 246
Mri, antibody-guided scintigraphy, and glucose metabolism in uveal melanoma 245
Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease 245
Relation between dobutamine trans-thoracic echocardiography, 99Tcm-MIBI and 18FDG uptake in chronic coronary artery disease 242
[(11)C]Choline Positron Emission Tomography/Computerized Tomography to Restage Prostate Cancer Cases With Biochemical Failure After Radical Prostatectomy and No Disease Evidence on Conventional Imaging 242
Time dependence of residual tissue viability after myocardial infarction assessed by [18F]fluorodeoxyglucose and positron emission tomography 240
New positron emission tomography derived parameters as predictive factors for recurrence in resected stage I non-small cell lung cancer 238
Automatic registration of PET and CT studies for clinical use in thoracic and abdominal conformal radiotherapy 236
Multifocal, persistent cardiac uptake of [18-F]-Fluoro-Deoxy-Glucose detected by positron emission tomography in patients with acute myocardial infarction 236
Fluorodeoxyglucose uptake measured by positron emission tomography and standardized uptake value predicts long-term survival of CT screening detected lung cancer in heavy smokers 236
Identification and revascularization of hibernating myocardium inangina-free patients with left ventricular dysfunction 235
Inflammatory pseudotumor of mediastinum treated with tomotherapy and monitored with FDG-PET/CT: Case report and literature review 235
Erratum: A procedure for wall detection in [18F]FDG positron emission tomography heart studies (European Journal of Nuclear Medicine (1996) 23 (18-24)) 235
Respiratory gated PET/CT in a European multicentre retrospective study: added diagnostic value in detection and characterization of lung lesions 234
Evaluation of the clinical performances of a large Nal(TI) crystal 3D PET scanner 230
Fluorodeoxyglucose positron emission tomography improves preoperative staging of resectable lung metastasis 228
Value of integrated PET/CT for lesion localisation in cancer patients: A comparative study 228
Feasibility of [F-18]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer 227
Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results 224
Relation between myocardial 18F-FDG uptake in the fasting state and coronary angiography in patients with coronary artery disease 223
Exercise-induced ischemic arrhythmias in patients with previous myocardial infarction: role of perfusion and tissue viability 222
Positive [11c]choline and negative [18F]FDG with positron emission tomography in recurrence of prostate cancer 220
18-FDG positron emission tomography in the evaluation of malignant pleural diseases - A pilot study 220
Spatial registration of echocardiographic and positron emission tomographic heart studies 218
Role of Computed Tomography and 18F-Fluorodeoxyglucose Positron Emission Tomography image fusion in conformal radiotherapy of non-small cell lung cancer: a comparison with standard techniques with and without elective nodal irradiation 216
Specificity and sensitivity of exercise-induced ST segment elevation for detection of residual viability: comparison with fluorodeoxyglucose and positron emission tomography 216
Assessment of Residual Viability by Enoximone Echocardiography in Patients with Previous Myocardial Infarction Correlation with Positron Emission Tomographic Studies and Functional Follow-Up 210
Helical tomotherapy for scalp recurrence of primary eccrine mucinous adenocarcinoma 209
A simplified method to integrate metabolic images in stereotactic procedures using a PET/CT scanner 208
Predictors of PSMA PET Positivity: Analysis in a Selected Cohort of Biochemical Recurrence Prostate Cancer Patients after Radical Prostatectomy 206
Assessment of CABG-related risk in patients with CAD and LVD. Contribution of PET with [18F]FDG to the assessment of myocardial viability 204
Automatic integration of PET/CT images for clinical use in radiotherapy 203
Target volume definition for stereotactic radiotherapy of lung metastases: A comparison between PET/CT and 4D-PET/CT 202
Recurrent hepatoblastoma in orthotopic transplanted liver: detection with FDG Positron Emission Tomography 202
Molecular imaging in prostate cancer: [11C]choline PET/CT 202
Concurrent pheochromocytoma, diabetes insipidus and cerebral venous thrombosis - a possible unique pathophysiological mechanism 201
Identification of hibernating myocardium: A comparison between dobutamine echocardiography and study of perfusion and metabolism in patients with severe left ventricular dysfunction 200
Rest distribution of 99mTc-MIBI in patients with coronary artery disease assessed by SPECT: Comparison with the distribution of [18F]FDG assessed by PET 197
Correlation of SPECT and PET cardiac images by a surface matching registration technique 196
PET-CT and breast cancer 192
Two dimensional vs three-dimentional imaging in whole boby oncologic PET/CT: A discovery-STE phantom and patient study 188
New radiopharmaceuticals and imaging of the heart receptors 186
Myocardial viability assessed with fluorodeoxyglucose and PET in patients with Q wave myocardial infarction receiving thrombolysis: relationship to coronary anatomy and ventricular function 185
A procedure for patient repositioning and compensation for misalignment between transmission and emission data in PET heart studies 185
Value of [11C]choline-positron emission tomography for re-staging prostate cancer: A comparison with [18F]fluorodeoxyglucose-positron emission tomography 184
Salvage therapy with temozolomide in an immunocompetent patient with primary brain lymphoma 182
The prognostic power of [11C]methionine PET in IDH-wildtype diffuse gliomas with lower-grade histological features: venturing beyond WHO classification 181
Advanced ovarian carcinoma: Usefulness of [18F]FDG-PET in combination with CT for lesion detection after primary treatment 180
Application of a surface matching image registration technique to the correlation of cardiac studies in positron emission tomography (PET) by transmission images 179
Is there a role for FDG PET in the diagnosis of musculoskeletal neoplasms? 175
PET/CT in diagnostic oncology 174
PET/CT and breast cancer 174
Clinical application of 11C-Choline PET in patients with biochemical relapse of prostate cancer 169
Abnormal myocardial glucose handling in patients with syndrome X: Effect of beta-adrenergic blockade 168
Lack of prognostic value of 99mTc MIBI rest, 18F FDG and 201Tl rest/redistribution on PTCA outcome of patients with moderate left ventricle dysfunction 166
Glucose metabolism and pathological findings in uveal melanoma preliminary results 166
Rapid spread of PET in workup of cancer - But Sweden lags behind [Snabb ökning av PET i utredning av cancer - Men sverige släpar efter] 152
Increased [11C]Choline uptake in bronchioalveolar cell carcinoma with negative [18F]FDG uptake. A PET/CT and pathology study 150
Ruolo della tomografia ad emissione di positroni nella caratterizzazione dei noduli solitari polmonari indeterminati 148
Correction measured by attenuation in tomographic heart studies with single photon emission with thallium 201. Comparison with positron- emission tomographic studies with ammonium marked with nitrogen 145
PET-Guided target delineation in a patient with lung cancer. 141
Regional glucose utilization in infarcted and remote myocardium: Its relation to coronary anatomy and perfusion 140
Comparison of dual-head coincidence PET versus ring PET in tumor patients 132
Tomoterapia ed ipofrazionamento 130
Next-generation radiomic sequencing in non-small cell lung cancer: an alternative model to predict mutations from [18F]FDG PET/CT 125
Imaging myocardial innervation in congestive heart failure: methods and clinical implications 108
Totale 23.806
Categoria #
all - tutte 75.366
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.366


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.327 90 170 153 145 71 71 74 79 64 74 135 201
2022/20232.265 268 607 174 250 177 367 18 96 163 43 79 23
2023/20241.392 67 54 81 64 192 371 271 36 71 21 29 135
2024/20253.214 176 473 165 138 237 102 131 151 251 432 434 524
2025/20267.736 656 498 532 753 757 464 1.144 412 686 626 686 522
2026/202721 21 0 0 0 0 0 0 0 0 0 0 0
Totale 23.806